查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945256

2026年全球頭頸癌診斷市場報告

Head And Neck Cancer Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，頭頸癌診斷市場發展迅速，預計將從2025年的20.3億美元成長到2026年的23.8億美元，複合年成長率達17.1%。過去幾年的成長可歸因於頭頸癌發病率的上升、診斷成像基礎設施的擴建、早期癌症檢測意識提升、基於切片檢查的診斷技術的進步以及專業腫瘤服務的普及。

預計未來幾年，頭頸癌診斷市場將快速成長，到2030年將達到45億美元，複合年成長率（CAGR）為17.3%。預測期內的成長要素包括：個人化癌症診斷的日益普及、人工智慧成像技術投資的增加、分子診斷檢測的擴展、對早期檢測項目的日益重視以及數位病理解決方案的日益整合。預測期內的主要趨勢包括：先進影像技術的日益普及、分子和基因檢測的日益廣泛應用、人工智慧在癌症檢測中的應用日益深入、早期篩檢計畫的擴展以及對精準腫瘤學的日益重視。

個人化醫療的日益普及預計將推動頭頸癌診斷市場的成長。個人化醫療是指根據每位患者的個別特徵選擇量身定做的治療方法，以最佳化治療效果並最大限度地減少副作用。精準影像和個人化後續觀察對於有效管理頭頸癌至關重要。例如，根據美國非營利組織「個人化醫療聯盟」（Personalized Medicine Coalition）統計，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化治療方案，較2022年的6種核准顯著增加。個人化醫療的普及反映了推動頭頸癌診斷市場成長的關鍵趨勢。

頭頸癌診斷市場的主要企業正積極開發新產品，例如抗體，以獲得競爭優勢。抗體是免疫系統對外來物產生的蛋白質。例如，2023年2月，總部位於瑞士的製藥公司羅氏控股（Roche Holding AG）推出了IDH1 R132H (MRQ-67)兔單株抗體和ATRX兔多株抗體，為腦腫瘤診斷提供了先進的功能。這些抗體旨在特異性檢測IDH1和ATRX基因的突變，為臨床醫生提供重要的診斷和預後資訊。 IDH1抗體可辨識成人膠質瘤和急性骨髓性白血病（AML）中的IDH1 R132H突變，有助於臨床試驗中的患者分層。 ATRX抗體可檢測ATRX基因的突變，為治療IDH突變型膠質瘤的臨床醫師提供寶貴的資訊。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球頭頸癌診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧與自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 先進診斷影像技術的應用日益廣泛
    • 分子和基因檢測技術的廣泛應用
    • 人工智慧在癌症檢測的應用進展
    • 擴大早期篩檢計劃
    • 日益關注精準腫瘤學

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷中心
  • 腫瘤診所
  • 專科癌症醫院
  • 研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球頭頸癌診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球頭頸癌診斷市場規模、比較及成長率分析
  • 全球頭頸癌診斷市場表現：規模與成長，2020-2025年
  • 全球頭頸癌診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 透過診斷方法
  • 診斷影像設備、內視鏡設備、切片檢查篩檢試驗
  • 透過測試方法
  • 組織病理學和細胞學、免疫組織化學和生物標記檢測、分子診斷、液態生物檢體、細胞遺傳學和螢光原位雜合技術（FISH）、照護現場和快速檢測、基於人工智慧的圖像分析和電腦輔助診斷
  • 按頻道
  • 醫院及院內診斷科室、獨立診斷及影像中心及專科診所
  • 按類型細分：診斷成像設備
  • 電腦斷層掃描（CT）、磁振造影（MRI）、正子斷層掃描（PET）、X光
  • 按類型細分：內視鏡設備
  • 硬式內視鏡、軟式內視鏡、影像內視鏡系統
  • 按類型細分：切片檢查篩檢測試
  • 細針穿刺切片檢查（FNA）、粗針穿刺切片、手術切片檢查

第10章 區域與國家分析

  • 全球頭頸癌診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球頭頸癌診斷市場：依國家、表現及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 頭頸癌診斷市場：競爭格局及市場佔有率（2024年）
  • 頭頸癌診斷市場：公司估值矩陣
  • 頭頸癌診斷市場：公司概況
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • GE HealthCare Technologies Inc.
    • Canon Medical Systems Corporation
    • Shimadzu Corporation

第37章：其他領先和創新企業

  • Carestream Health Inc., Agilent Technologies Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., QIAGEN NV, Illumina Inc., Exact Sciences Corp., Hologic Inc., Sysmex Corporation, Cepheid Inc., NanoString Technologies Inc., Myriad Genetics Inc., Bio-Techne Corp., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年頭頸癌診斷市場：提供新機會的國家
  • 2030年頭頸癌診斷市場：新興細分市場機會
  • 2030年頭頸癌診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MHNCD01_G26Q1

Head and neck cancer diagnostics involve the identification and confirmation of malignant cells in the head and neck region through a combination of methods, including physical examination, imaging tests, medical history assessment, and tissue biopsy. This diagnostic process is commonly applied in the treatment of squamous cell carcinomas, laryngeal cancer, and hypopharyngeal cancer.

The primary methods employed in head and neck cancer diagnostics include diagnostic imaging equipment, endoscopy screening equipment, biopsy screening tests, dental diagnostic methods, and others. Diagnostic imaging equipment comprises various medical tools utilized to generate images of the internal organs and tissues for diagnostic purposes. These diagnostic processes involve multiple channels, including retail and specialty pharmacies, hospital pharmacies, and online pharmacies. The end-users benefiting from these diagnostic methods encompass hospitals, diagnostic centers, and others.

Tariffs are impacting the head and neck cancer diagnostics market by increasing costs of imported imaging equipment, diagnostic reagents, endoscopy systems, biopsy tools, and advanced laboratory instruments. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end diagnostic technologies, while Asia-Pacific faces cost pressures on equipment procurement and maintenance. These tariffs are increasing diagnostic service costs and delaying technology upgrades. However, they are also encouraging domestic diagnostic equipment manufacturing, regional reagent production, and investment in localized diagnostic innovation.

The head and neck cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides head and neck cancer diagnostics market statistics, including head and neck cancer diagnostics industry global market size, regional shares, competitors with a head and neck cancer diagnostics market share, detailed head and neck cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the head and neck cancer diagnostics industry. This head and neck cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The head and neck cancer diagnostics market size has grown rapidly in recent years. It will grow from $2.03 billion in 2025 to $2.38 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to increasing incidence of head and neck cancers, expansion of diagnostic imaging infrastructure, rising awareness of early cancer detection, growth in biopsy-based diagnostics, availability of specialized oncology services.

The head and neck cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of personalized cancer diagnostics, rising investments in AI-enabled imaging, expansion of molecular diagnostic testing, growing focus on early detection programs, increasing integration of digital pathology solutions. Major trends in the forecast period include increasing adoption of advanced imaging-based diagnostics, rising use of molecular and genetic testing, growing integration of ai in cancer detection, expansion of early-stage screening programs, enhanced focus on precision oncology.

The increasing adoption of personalized medicines is expected to contribute to the growth of the head and neck cancer diagnostics market. Personalized medicine involves tailoring medical treatment to the individual characteristics of each patient, optimizing treatment outcomes, and minimizing side effects. Precision imaging and individualized follow-up care are crucial in managing head and neck cancers effectively. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized therapies for patients with rare diseases, marking a substantial rise from the six approvals recorded in 2022. This adoption of personalized medicine reflects a significant trend driving the growth of the head and neck cancer diagnostics market.

Major companies in the head and neck cancer diagnostics market are actively developing new products, such as antibodies, to gain a competitive advantage. Antibodies are proteins produced by the immune system in response to foreign substances. For instance, in February 2023, Roche Holding AG, a Switzerland-based pharmaceutical company, launched IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and ATRX Rabbit Polyclonal Antibody, offering advanced features in brain cancer diagnostics. These antibodies are specifically designed to detect mutations in the IDH1 and ATRX genes, providing clinicians with crucial diagnostic and prognostic information. The IDH1 antibody identifies the IDH1 R132H mutation in adult-type gliomas and acute myeloid leukemia (AML), aiding patient stratification for clinical trials. The ATRX antibody detects mutations in the ATRX gene, offering valuable insights for clinicians managing IDH-mutant gliomas.

In June 2023, Quest Diagnostics Inc., a US-based leading clinical laboratory services company, completed the acquisition of Haystack Oncology, an early-stage oncology company specializing in highly sensitive circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) liquid biopsy testing, for approximately $300 million. Through this acquisition, Quest aims to expand its precision oncology capabilities by integrating Haystack Oncology's advanced molecular and MRD testing into its cancer diagnostics portfolio.

Major companies operating in the head and neck cancer diagnostics market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Canon Medical Systems Corporation, Shimadzu Corporation, Carestream Health Inc., Agilent Technologies Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Illumina Inc., Exact Sciences Corp., Hologic Inc., Sysmex Corporation, Cepheid Inc., NanoString Technologies Inc., Myriad Genetics Inc., Bio-Techne Corp., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., VolitionRx Ltd., Perseus Proteomics Inc., Oncgnostics GmbH

North America was the largest region in the head and neck cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the head and neck cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The head and neck cancer diagnostic market consists of revenues earned by entities by providing panoramic dental X-ray, magnetic resonance imaging (MRI), and computerized tomography (CT) scans. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Head And Neck Cancer Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses head and neck cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for head and neck cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The head and neck cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Diagnostic Method: Diagnostic Imaging Equipment; Endoscopy Screening Equipment; Biopsy Screening Tests
  • 2) By Assay Type: Histopathology And Cytology; Immunohistochemistry And Biomarker Testing; Molecular Diagnostics; Liquid Biopsy; Cytogenetics And FISH; Point-Of-Care And Rapid Tests; AI-Based Image Analysis And Computer-Aided Diagnostics
  • 3) By Channel: Hospitals & Hospital-Based Diagnostic Departments; Independent Diagnostic & Imaging Centers; Specialty Clinics
  • Subsegments:
  • 1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; X-rays
  • 2) By Endoscopy Screening Equipment: Rigid Endoscopes; Flexible Endoscopes; Video Endoscopy Systems
  • 3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy
  • Companies Mentioned: Siemens Healthineers AG; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Canon Medical Systems Corporation; Shimadzu Corporation; Carestream Health Inc.; Agilent Technologies Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.; QIAGEN N.V.; Illumina Inc.; Exact Sciences Corp.; Hologic Inc.; Sysmex Corporation; Cepheid Inc.; NanoString Technologies Inc.; Myriad Genetics Inc.; Bio-Techne Corp.; Caris Life Sciences Inc.; HTG Molecular Diagnostics Inc.; VolitionRx Ltd.; Perseus Proteomics Inc.; Oncgnostics GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Head And Neck Cancer Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Head And Neck Cancer Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Head And Neck Cancer Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Head And Neck Cancer Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
    • 4.1.5 Industry 4.0 And Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Advanced Imaging-Based Diagnostics
    • 4.2.2 Rising Use Of Molecular And Genetic Testing
    • 4.2.3 Growing Integration Of Ai In Cancer Detection
    • 4.2.4 Expansion Of Early-Stage Screening Programs
    • 4.2.5 Enhanced Focus On Precision Oncology

5. Head And Neck Cancer Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Centers
  • 5.3 Oncology Clinics
  • 5.4 Specialty Cancer Hospitals
  • 5.5 Research Institutes

6. Head And Neck Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Head And Neck Cancer Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Head And Neck Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Head And Neck Cancer Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Head And Neck Cancer Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Head And Neck Cancer Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Head And Neck Cancer Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Head And Neck Cancer Diagnostics Market Segmentation

  • 9.1. Global Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests
  • 9.2. Global Head And Neck Cancer Diagnostics Market, Segmentation By Assay Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Histopathology And Cytology, Immunohistochemistry And Biomarker Testing, Molecular Diagnostics, Liquid Biopsy, Cytogenetics And FISH, Point-Of-Care And Rapid Tests, AI-Based Image Analysis And Computer-Aided Diagnostics
  • 9.3. Global Head And Neck Cancer Diagnostics Market, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals & Hospital-Based Diagnostic Departments, Independent Diagnostic & Imaging Centers, Specialty Clinics
  • 9.4. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Diagnostic Imaging Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays
  • 9.5. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Endoscopy Screening Equipment, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems
  • 9.6. Global Head And Neck Cancer Diagnostics Market, Sub-Segmentation Of Biopsy Screening Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy

10. Head And Neck Cancer Diagnostics Market Regional And Country Analysis

  • 10.1. Global Head And Neck Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Head And Neck Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Head And Neck Cancer Diagnostics Market

  • 11.1. Asia-Pacific Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Head And Neck Cancer Diagnostics Market

  • 12.1. China Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Head And Neck Cancer Diagnostics Market

  • 13.1. India Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Head And Neck Cancer Diagnostics Market

  • 14.1. Japan Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Head And Neck Cancer Diagnostics Market

  • 15.1. Australia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Head And Neck Cancer Diagnostics Market

  • 16.1. Indonesia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Head And Neck Cancer Diagnostics Market

  • 17.1. South Korea Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Head And Neck Cancer Diagnostics Market

  • 18.1. Taiwan Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Head And Neck Cancer Diagnostics Market

  • 19.1. South East Asia Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Head And Neck Cancer Diagnostics Market

  • 20.1. Western Europe Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Head And Neck Cancer Diagnostics Market

  • 21.1. UK Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Head And Neck Cancer Diagnostics Market

  • 22.1. Germany Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Head And Neck Cancer Diagnostics Market

  • 23.1. France Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Head And Neck Cancer Diagnostics Market

  • 24.1. Italy Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Head And Neck Cancer Diagnostics Market

  • 25.1. Spain Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Head And Neck Cancer Diagnostics Market

  • 26.1. Eastern Europe Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Head And Neck Cancer Diagnostics Market

  • 27.1. Russia Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Head And Neck Cancer Diagnostics Market

  • 28.1. North America Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Head And Neck Cancer Diagnostics Market

  • 29.1. USA Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Head And Neck Cancer Diagnostics Market

  • 30.1. Canada Head And Neck Cancer Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Head And Neck Cancer Diagnostics Market

  • 31.1. South America Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Head And Neck Cancer Diagnostics Market

  • 32.1. Brazil Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Head And Neck Cancer Diagnostics Market

  • 33.1. Middle East Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Head And Neck Cancer Diagnostics Market

  • 34.1. Africa Head And Neck Cancer Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Head And Neck Cancer Diagnostics Market, Segmentation By Diagnostic Method, Segmentation By Assay Type, Segmentation By Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Head And Neck Cancer Diagnostics Market Regulatory and Investment Landscape

36. Head And Neck Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Head And Neck Cancer Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Head And Neck Cancer Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Head And Neck Cancer Diagnostics Market Company Profiles
    • 36.3.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Canon Medical Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Shimadzu Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Head And Neck Cancer Diagnostics Market Other Major And Innovative Companies

  • Carestream Health Inc., Agilent Technologies Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., QIAGEN N.V., Illumina Inc., Exact Sciences Corp., Hologic Inc., Sysmex Corporation, Cepheid Inc., NanoString Technologies Inc., Myriad Genetics Inc., Bio-Techne Corp., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc.

38. Global Head And Neck Cancer Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Head And Neck Cancer Diagnostics Market

40. Head And Neck Cancer Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Head And Neck Cancer Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Head And Neck Cancer Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Head And Neck Cancer Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer